[Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
Larsen
Jørgen Falck
JF
Amtssygehuset i Herlev, Gynaekologisk-Obstetrisk Afdeling, H:S Rigshospitalet, Juliane Marie Centret, Obstetrisk Klinik. falcklarsen@dadlnet.dk
Bock
Johannes E
JE
Jørgensen
Jan R
JR
D000028:Abortion, Induced / Q000009:adverse effects; D000022:Abortion, Spontaneous / Q000150:complications / Q000276:immunology; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology*; D011261:Pregnancy Trimester, First / Q000276:immunology; D011262:Pregnancy Trimester, Second / Q000276:immunology; D011271:Pregnancy, Ectopic / Q000150:complications / Q000276:immunology; D012203:Rh Isoimmunization / Q000209:etiology / Q000517:prevention & control*; D018029:Rho(D) Immune Globulin / Q000008:administration & dosage*; D012307:Risk Factors
D018029:Rho(D) Immune Globulin
Forebyggelse af Rhesusimmunisering. I. Teoretisk baggrund og imødegåelse af risiko i første halvdel af graviditeten.